Trademarkia Logo

Canada

C$
Trademark Search in Canada
COMBOCAP

View On IC.GC.CA

COMBOCAP
REGISTERED

on 26 Feb 2021

Last Applicant/ Owned by

COMBOCAP INC.

747 Third AvenueNew York, NY 10017

US

Serial Number

1864579 filed on 25th Oct 2017

Registration Number

TMA1094473 registered on 26th Feb 2021

Registration expiry Date

26th Feb 2031

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

COMBOCAP

Trademark usage description

pharmaceutical and nutraceutical preparations, namely, a multi-compartment capsule that allows for the simultaneous, controlled and extended release o Read More

Classification Information

Class [005]
Pharmaceutical and nutraceutical preparations, namely, a multi-compartment capsule that allows for the simultaneous, controlled and extended release of ingredients for use as a dietary supplement for general health and wellbeing, and for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory and gastrointestinal, diseases and disorders in humans and animals; Pharmaceutical and nutraceutical preparations, namely, a multi-compartment capsule that allows for the simultaneous, controlled and extended release of ingredients for the treatment of viral related diseases and disorders in humans, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome, for the treatment of disorders of the endocrine system, namely, growth and thyroid disorders, for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, for the treatment of metabolic disorders, namely , bulimia nervosa, anorexia, obesity and hypothyroidism, for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases , for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, for the treatment of autoimmune diseases, for regulating the immune system, hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, for use in dermatology, namely, for treatment of dermatitis, skin pigmentation diseases, eczema, psoriasis; drug delivery agents in the form of multi-compartment capsules that facilitate delivery of a wide range of pharmaceuticals and nutraceuticals; empty multi-compartment capsules for nutraceutical and pharmaceutical uses.

Classification kind code

11

Class [040]
Capsule filling services for others, namely, filling multi-compartment capsules with medicinal, pharmaceutical and nutritional ingredients; custom manufacture of multi-compartment capsules for others.

Classification kind code

11

Mark Details

Serial Number

1864579

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 23rd Sept 2020		Registration Pending
Submitted for opposition 42
on 25th Mar 2020		Advertised
Submitted for opposition 26
on 5th Mar 2020		Approved
Submitted for opposition 27
on 5th Mar 2020		Approval Notice Sent
Submitted for opposition 15
on 26th Jun 2019		Correspondence Created
Submitted for opposition 22
on 29th Nov 2018		Search Recorded
Submitted for opposition 20
on 29th Nov 2018		Examiner's First Report
Submitted for opposition 1
on 26th Oct 2017		Created
Submitted for opposition 31
on 26th Oct 2017		Formalized
Submitted for opposition 30
on 25th Oct 2017		Filed